TriSalus Life Sciences, Inc. - Warrant — Cash Flow (NASDAQ:TLSIW)

Financials

Cash from operating activities -1.74 M-2.74 M-50.05 M-40.84 M-18.01 M -19.99 M Cash from investing activities 60 K233.2 M-2.12 M-345 K-838 K -265 K Cash from financing activities 544 K-230.51 M54.63 M37.94 M30.76 M 63.46 M Free cash flow -1.74 M-2.74 M-50.05 M-40.84 M-18.93 M -20.3 M

TLSIW

Financials

News

TriSalus Life Sciences, Inc. (TLSI) Discusses Pressure-Enabled Drug Delivery and Advances in Uterine Fibroid Embolization Transcript

TriSalus Life Sciences, Inc. (TLSI) Q2 2025 Earnings Call Transcript

TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings Call Transcript